Search results for "Pyoderma"

showing 4 items of 14 documents

Pyoderma gangrenosum, acne, hidradenitis suppurativa syndrome associated with type 1 diabetes mellitus treated with adalimumab

2019

Type 1 diabetesmedicine.medical_specialtybusiness.industryTreatment outcomeMEDLINEDermatologymedicine.diseaseDermatologyDiabetes mellitusmedicineAdalimumabHidradenitis suppurativaPyoderma gangrenosum acne hidradenitis suppurativabusinessPyoderma gangrenosumAcnemedicine.drug
researchProduct

Diagnosis and novel clinical treatment strategies for pyoderma gangrenosum

2019

Introduction: Pyoderma gangrenosum (PG) is a noninfectious, reactive inflammatory neutrophilic dermatosis that is commonly associated with autoimmune and neoplastic disorders. There are emerging diagnostic tools and treatment options for PG.Area covered: The diagnosis of PG should be seriously considered when managing ulcers to avoid unnecessary medical and surgical complications with prompt and suitable treatment. There are no standardized treatment guidelines for PG, and current therapy largely depends on the severity and progression of the disease. Systemic corticosteroids, immunosuppressant therapy, and biologic agents remain mainstay therapies. In this article, we present a literature …

medicine.medical_specialtyDiseaseDiagnostic toolsSeverity of Illness Index030226 pharmacology & pharmacySystemic therapyBiological Factors03 medical and health sciences0302 clinical medicineAdrenal Cortex HormonesmedicineHumansPharmacology (medical)General Pharmacology Toxicology and PharmaceuticsIntensive care medicineClinical treatmentbusiness.industryGeneral MedicineGold standard (test)medicine.diseasePyoderma GangrenosumBiologic AgentsNeutrophilic dermatosis030220 oncology & carcinogenesisDisease ProgressionDermatologic AgentsbusinessImmunosuppressive AgentsPyoderma gangrenosumExpert Review of Clinical Pharmacology
researchProduct

PA1 INFLIXIMAB AND TOPICAL TACROLIMUS ADMINISTRATION EFFECTIVE IN THE TREATMENT OF PYODERMA GANGRENOSUM

2009

medicine.medical_specialtyHepatologybusiness.industryGastroenterologymedicineTopical tacrolimusmedicine.diseasebusinessAdministration (government)DermatologyPyoderma gangrenosumInfliximabmedicine.drugDigestive and Liver Disease
researchProduct

Multifocal Pyoderma Gangrenosum Resistant to Infliximab in Active Ulcerative Colitis: Donʼt Forget the Role of Cyclosporin

2012

medicine.medical_specialtybusiness.industryGastroenterologymedicineImmunology and Allergymedicine.diseasebusinessUlcerative colitisDermatologyPyoderma gangrenosumInfliximabmedicine.drugInflammatory Bowel Diseases
researchProduct